Background Circle Background Circle

Southern California Is Origin of New COVID-19 Variant

Southern California Is Origin of New COVID-19 Variant

FRIDAY, Feb. 12, 2021 (HealthDay News) — A new variant of COVID-19 found in Southern California is coursing across the United States and around the world, a new study finds.

The variant — called CAL.20C — was first found in July in Los Angeles County. It reappeared in Southern California in October, then spread in November and December, with a regional surge in coronavirus cases.

The variant now makes up nearly half of COVID-19 cases in Southern California.

It’s not clear whether CAL.20C might be more lethal than current coronavirus variants, or whether it might resist current vaccines. New research is underway Cedars-Sinai in Los Angeles to help answer those questions.

“New variants do not always affect the behavior of a virus in the body,” said study co-author Dr. Eric Vail, an assistant professor of pathology at the Cedars-Sinai Center for Bioinformatics and Functional Genomics.

The new variant has spread to 19 states and the District of Columbia, as well six other countries, according to the report, published Feb. 11 in the Journal of the American Medical Association.

As of Jan. 22, the variant had been found in Alaska, Arizona, California, Connecticut, Georgia, Hawaii, Maryland, Michigan, New Mexico, Nevada, New York, Oregon, Rhode Island, South Carolina, Texas, Utah, Washington, Wisconsin, Wyoming and Washington, D.C. It was also found in Australia, Denmark, Israel, New Zealand, Singapore and the United Kingdom, according to the new study.

Study co-author Jasmine Plummer said people traveling from Southern California are carrying CAL.20C to other places. Plummer is a research scientist at the Cedars-Sinai Center for Bioinformatics and Functional Genomics in Los Angeles.

“CAL.20C is moving, and we think it is Californians who are moving it,” Plummer said in center news release.

Vail said researchers are keenly interested in CAL.20C, because it involves the so-called spike protein, which enables the SARS-CoV-2 virus to invade and infect normal cells.


More information

For more on COVID-19, visit the U.S. Centers for Disease Control and Prevention.


SOURCE: Cedars-Sinai, Los Angeles, news release, Feb. 11, 2021

Source link

You Might Also Like!
Another new coronavirus variant seen in the UK
Another new coronavirus variant seen in the UK

It has similar mutations to the South Africa variant, so how worrying is it? Source link

COVID-19 vaccines: Safety, side effects — and coincidence
COVID-19 vaccines: Safety, side effects — and coincidence

As the pandemic rages on, it’s increasingly clear that widespread vaccination is essential to help contain it. Physical distancing, universal ENGAGE+

Give Hospitalized COVID-19 Patients Blood Thinners
Give Hospitalized COVID-19 Patients Blood Thinners

By Robert Preidt HealthDay Reporter FRIDAY, Feb. 12, 2021 (HealthDay News) -- Giving blood thinners to COVID-19 patients soon after ENGAGE+

Covid-19: Vaccine as good in 'real world' as in trial in Israel
Covid-19: Vaccine as good in 'real world' as in trial in Israel

The Pfizer vaccine prevented 94% of infections in a group of 600,000 Israeli patients. Source link

Walmart, Walgreens, CVS to Offer COVID-19 Vaccines
Walmart, Walgreens, CVS to Offer COVID-19 Vaccines

Feb. 11, 2021 -- Walmart, Sam’s Club, and Walgreens will begin offering COVID-19 vaccines on Friday through the Federal Retail ENGAGE+

Experts Debunk COVID-19 Vaccine-Shingles Link
Experts Debunk COVID-19 Vaccine-Shingles Link

Feb. 9, 2021 -- The Reddit message board user was looking for others in similar misery to share their stories. ENGAGE+

Covid: What is the government doing about the South Africa variant?
Covid: What is the government doing about the South Africa variant?

Then at its meeting on 21 January, Sage said: "No intervention, other than a complete, pre-emptive closure of borders, or ENGAGE+

Beyond COVID-19: Can mRNA Treat Diseases, Too?
Beyond COVID-19: Can mRNA Treat Diseases, Too?

Secondly, the FDA has yet to greenlight any of these treatments. What’s more, some early trials of mRNA therapies have ENGAGE+